ALDH Modulator Compounds for Cytotoxic Aldehyde Detoxification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for agents that can modulate aldehyde dehydrogenase (ALDH) enzymatic activity to address the accumulation of cytotoxic aldehydes and associated diseases, as existing methods are inadequate in managing conditions such as neurodegenerative diseases, cancer, and liver diseases.
Innovation Solution
Development of compounds that act as modulators of ALDH enzymatic activity, specifically agonists that increase the activity of ALDH isozymes like ALDH1, ALDH2, and ALDH3, to enhance the oxidation of aldehydes to their corresponding acids, thereby reducing toxic aldehyde levels and treating associated disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ALDH enzymatic activity is increased to detoxify cytotoxic aldehydes, then therapeutic effectiveness is improved, but existing methods are inadequate and lack sufficient potency
Solution Approach 1:
The patent applies parameter changes by developing compounds with optimized molecular structures that specifically enhance ALDH enzymatic activity. The compounds represent a quantitative improvement in enzyme modulation capability, transitioning from inadequate existing methods to potent activators that reliably increase ALDH activity across multiple isozymes.
2Productivity
If compounds are developed to modulate ALDH activity, then detoxification capability is improved, but complexity of drug development increases
Solution Approach 1:
The patent employs universality by creating compounds that can modulate multiple ALDH isozymes (ALDH1, ALDH2, ALDH3) simultaneously. This multi-functional approach allows a single compound to address various detoxification needs across different tissues and disease states, improving overall detoxification capability while avoiding the complexity of developing separate agents for each isozyme.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively increase ALDH enzymatic activity, leading to reduced levels of cytotoxic aldehydes and improved treatment outcomes for conditions like ischemic stress, cancer, and skin damage, demonstrating therapeutic potential in detoxification and disease management.
Implementation Method 1
ALDH enzymes that oxidize aldehydes to their corresponding acids
Data Source
AI summary
The present disclosure provides compounds that function as modulators of aldehyde dehydrogenase (ALDH) enzymatic activity, as well as compositions and formulations comprising the compounds. The present disclosure provides therapeutic methods involving administering a subject compound, or a subject pharmaceutical composition.